We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
In the latest close session, Cardinal Health (CAH - Free Report) was down 1.64% at $154.31. The stock fell short of the S&P 500, which registered a gain of 1.56% for the day. On the other hand, the Dow registered a gain of 1.29%, and the technology-centric Nasdaq increased by 2.21%.
Shares of the prescription drug distributor witnessed a gain of 3.05% over the previous month, beating the performance of the Medical sector with its gain of 2.08%, and the S&P 500's gain of 0.41%.
The upcoming earnings release of Cardinal Health will be of great interest to investors. The company's earnings report is expected on October 30, 2025. The company's earnings per share (EPS) are projected to be $2.22, reflecting a 18.09% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $59.05 billion, indicating a 12.96% increase compared to the same quarter of the previous year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $9.42 per share and revenue of $249.31 billion, indicating changes of +14.32% and +12.01%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for Cardinal Health. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.03% higher. Cardinal Health is holding a Zacks Rank of #2 (Buy) right now.
Investors should also note Cardinal Health's current valuation metrics, including its Forward P/E ratio of 16.66. This valuation marks a premium compared to its industry average Forward P/E of 14.
Meanwhile, CAH's PEG ratio is currently 1.33. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Dental Supplies was holding an average PEG ratio of 1.46 at yesterday's closing price.
The Medical - Dental Supplies industry is part of the Medical sector. With its current Zacks Industry Rank of 82, this industry ranks in the top 34% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest close session, Cardinal Health (CAH - Free Report) was down 1.64% at $154.31. The stock fell short of the S&P 500, which registered a gain of 1.56% for the day. On the other hand, the Dow registered a gain of 1.29%, and the technology-centric Nasdaq increased by 2.21%.
Shares of the prescription drug distributor witnessed a gain of 3.05% over the previous month, beating the performance of the Medical sector with its gain of 2.08%, and the S&P 500's gain of 0.41%.
The upcoming earnings release of Cardinal Health will be of great interest to investors. The company's earnings report is expected on October 30, 2025. The company's earnings per share (EPS) are projected to be $2.22, reflecting a 18.09% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $59.05 billion, indicating a 12.96% increase compared to the same quarter of the previous year.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $9.42 per share and revenue of $249.31 billion, indicating changes of +14.32% and +12.01%, respectively, compared to the previous year.
Investors should also take note of any recent adjustments to analyst estimates for Cardinal Health. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.03% higher. Cardinal Health is holding a Zacks Rank of #2 (Buy) right now.
Investors should also note Cardinal Health's current valuation metrics, including its Forward P/E ratio of 16.66. This valuation marks a premium compared to its industry average Forward P/E of 14.
Meanwhile, CAH's PEG ratio is currently 1.33. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Dental Supplies was holding an average PEG ratio of 1.46 at yesterday's closing price.
The Medical - Dental Supplies industry is part of the Medical sector. With its current Zacks Industry Rank of 82, this industry ranks in the top 34% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.